Tag Archives: NIH

Dr. Petra Kaufmann Video Interview: Clinical and Translational Science Awards Program

lab_tech

Petra Kaufmann, MD, MSc, Director of the Division of Clinical Innovation at the National Institutes of Health, recently joined us in the BIO Buzz Center to discuss streamlining clinical trials through the Clinical and Translational Science Awards (CTSA) Program. As part of NIH’s National Center for Advancing Translational Sciences (NCATS), the CTSA program is designed to address the development and implementation of national standards and best practices for the full range of translation, from basic Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO Patient & Health Advocacy Summit: The Power of Partnerships

patient-summit-4

This week, the BIO Patient & Health Advocacy Summit powered partnerships in the industry to advance drug discovery by bringing together patient advocacy organizations, government agencies and industry leaders to discuss how to accelerate R&D, preserve patient access, leverage data and build collaborations focused on empowering patients. The rallying cry that reverberated throughout the event and over Twitter seemed clear from the beginning and Paul Hastings, Chairman and CEO of OncoMed Pharmaceuticals, Inc. captured it Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

NCATS SBIR Announces Funding For Biotechs and Small Business Technology Development

lab_tech

The NIH National Center for Advancing Translational Sciences (NCATS) is seeking qualified applicants for its Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. NCATS, which offers $17.6 million annually through these programs, has issued a call for applications for two funding opportunities: Contract funding to support small businesses and venture-backed technology development, due Nov. 5, 2014. Investigator-initiated grant funding,due Dec. 5, 2014. NCATS’ SBIR and STTR programs are engines of innovation Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Synthetic Biology: The Sword in the Stone to Defeat Devastating Diseases

shutterstock_27160801

On July 17th, 2014 the House held a hearing titled: Subcommittee on Research and Technology Hearing – Policies to Spur Innovative Medical Breakthroughs from Laboratories to Patients Witnesses Dr. Harold Varmus, Director, National Cancer Institute (NCI) at the National Institutes of Health (NIH) *(Really liked your DNA tie!) Dr. Marc Tessier-Lavigne, President and Carson Family Professor, Laboratory of Brain Development and Repair, The Rockefeller University Dr. Jay Keasling, Hubbard Howe Jr. Distinguished Professor of Biochemical Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , , , ,

21st Century Cures: Accelerating the Discovery-Development-Delivery Cycle

Fred-upton

How can we give patients faster access to innovative treatments and cures? That’s the question the House Energy and Commerce Committee is asking our nation’s foremost medical experts and innovators through white papers, hearings, and roundtables in an initiative we call 21st Century Cures. Our collaboration includes everyone from the National Institutes of Health and the Food and Drug Administration to patients, researchers, health entrepreneurs, and other thought leaders. Through 21st Century Cures, our goal Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,